Table 2.
Clinical characteristics of the patients included in the study.
| Group | n (%) | Age (Mean ± SD) | Sex (m/f) | JAK2V617 (Mut/WT) | CALR (Mut/WT/NA) |
|---|---|---|---|---|---|
| HC | 21 (20.8%) | 58 ± 5.78 | 12/9 | −/21/− | −/21/− |
| PV | 22 (21.8%) | 68.86 ± 14.57 | 14/8 | 22/−/− | −/1/21 |
| ET | 46 (45.5%) | 61.89 ± 16.53 | 18/28 | 24/22 | 9/23/14 |
| ST | 12 (11.9% | 60.17 ± 16.07 | 4/8 | −/12/− | −/12/− |
ET: essential thrombocythemia, f: female, HC: healthy control, m: male, Mut: mutant, n: sample size, NA: not available, PV: polycythemia vera, SD: standard deviation, ST: secondary thrombocythemia, WT: wild type.